axogen · 11 hours ago
Senior Dynamics 365 Techno-Functional Analyst
Axogen is a pioneering company dedicated to advancing science and technology for peripheral nerve repair and regeneration. They are seeking a Senior Dynamics 365 Techno-Functional Analyst to manage and enhance the Dynamics 365 platform, analyzing business processes, configuring and customizing the system, and collaborating with teams to optimize performance.
Responsibilities
Analyzing business processes
Configuring and customizing Dynamics 365
Managing integrations
Providing technical support to optimize system performance
Collaborating with cross-functional teams to identify requirements
Developing solutions
Maintaining system documentation
Qualification
Required
Strong expertise in Dynamics 365 configuration, customization, and administration
Experience with system integrations, data mapping, and migration processes
Knowledge of process analysis, workflow automation, and business requirements gathering
Proficiency in technical areas such as customization using Power Platform, Microsoft Azure, and related technologies
Strong problem-solving skills and attention to detail with the ability to work collaboratively across teams
Bachelor's degree in Computer Science, Information Technology, or a related field. Equivalent experience will be considered
Excellent communication skills to engage stakeholders and support end-users effectively
Preferred
Experience with ERP systems and project management methodologies is a plus
Company
axogen
AxoGen is a biotech company developing treatment options for the reconstruction and repair of peripheral nerve injuries.
H1B Sponsorship
axogen has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2024 (1)
2020 (1)
Funding
Current Stage
Public CompanyTotal Funding
$131.92MKey Investors
PDL Biopharma
2017-11-15Post Ipo Equity· $41M
2015-08-28Post Ipo Equity· $17.5M
2015-02-05Post Ipo Equity· $13M
Leadership Team
Recent News
2026-01-13
GlobeNewswire
2026-01-12
2025-12-05
Company data provided by crunchbase